Maria Lazarova

Associate Director, Business Development at Trialbee

Maria Lazarova, MSc has a diverse work experience spanning various industries and roles. Maria started their career in 2017 as a Service Monitor (Mystery Shopper) at Semani Bulgaria. In 2018, they had multiple summer internships at "DR. SHTEREV" Hospital and National Genetics Laboratory, where they gained exposure to different aspects of healthcare. Additionally, they worked as an Interpreter at Festo in 2018. Maria also completed a summer internship at AstraZeneca in 2018.

In 2019, Maria joined Cell Signaling Technology (CST) as a Scientific Sales Specialist for Europe, where they gained experience in scientific sales and customer relations.

From 2021 to 2022, Maria worked at Labcorp Drug Development, first as a Manager in Business Development for Full-Service Clinical, and then as a Manager in Inside Sales for Full-Service Clinical.

Since 2022, Maria has been working at Trialbee. Maria started as a Manager in Business Development for Patient Recruitment, then progressed to the role of Account Executive, and is currently serving as the Associate Director of Business Development.

Overall, Maria Lazarova's work experience showcases their versatility, with exposure to areas such as healthcare, sales, interpretation, and business development.

Maria Lazarova has a Diploma of Secondary Education in Biochemistry and Genetics from Spanish Secondary School "Miguel de Cervantes", which they obtained from 2011 to 2016. Maria then pursued a Bachelor of Science in Biochemistry and Genetics (Hons) at The University of Sheffield from 2016 to 2019. Currently, they are studying for a Master of Science in Clinical Trials (Merit) at The University of Edinburgh from 2019 to 2022.

Links

Previous companies

AstraZeneca logo
Cell Signaling Technology logo
LabCorp logo

Timeline

  • Associate Director, Business Development

    January, 2024 - present

  • Account Executive

    October, 2022

  • Manager, Business Development | Patient Recruitment

    April, 2022

View in org chart